↓ Skip to main content

The safety of over-the-counter niacin. A randomized placebo-controlled trial [ISRCTN18054903]

Overview of attention for article published in BMC Clinical Pharmacology, November 2003
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (97th percentile)

Mentioned by

news
1 news outlet
blogs
2 blogs
twitter
1 X user

Citations

dimensions_citation
52 Dimensions

Readers on

mendeley
32 Mendeley
Title
The safety of over-the-counter niacin. A randomized placebo-controlled trial [ISRCTN18054903]
Published in
BMC Clinical Pharmacology, November 2003
DOI 10.1186/1472-6904-3-4
Pubmed ID
Authors

Edward Mills, Jonathan Prousky, Gannady Raskin, Joel Gagnier, Beth Rachlis, Victor M Montori, David Juurlink

Abstract

Niacin is widely available over the counter (OTC). We sought to determine the safety of 500 mg immediate release niacin, when healthy individuals use them as directed.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 32 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 3%
Unknown 31 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 7 22%
Researcher 6 19%
Other 3 9%
Professor > Associate Professor 3 9%
Student > Bachelor 2 6%
Other 5 16%
Unknown 6 19%
Readers by discipline Count As %
Medicine and Dentistry 10 31%
Psychology 3 9%
Agricultural and Biological Sciences 2 6%
Nursing and Health Professions 2 6%
Environmental Science 1 3%
Other 6 19%
Unknown 8 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 24. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 February 2024.
All research outputs
#1,572,441
of 25,381,151 outputs
Outputs from BMC Clinical Pharmacology
#7
of 60 outputs
Outputs of similar age
#1,781
of 62,511 outputs
Outputs of similar age from BMC Clinical Pharmacology
#1
of 1 outputs
Altmetric has tracked 25,381,151 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 60 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.4. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 62,511 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them